Ruihui Pharmaceutical

Zhejiang Ruihui Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of high-end generic drugs and innovative small molecule therapeutics. The company focuses on major chronic disease areas, including cardiovascular diseases, metabolic disorders, and central nervous system conditions. Ruihui operates integrated R&D and GMP-certified manufacturing facilities, aiming to provide affordable, high-quality alternatives to blockbuster medications. Their portfolio includes several key products in the cardiovascular and antidiabetic markets, such as Rosuvastatin and Empagliflozin. The company is recognized for its commitment to quality and its role in the domestic pharmaceutical supply chain in China. Headquartered in Huzhou with R&D centers in Shanghai, Ruihui leverages advanced chemical synthesis and drug delivery technologies to enhance patient outcomes.